{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T02:26:05Z","timestamp":1785637565363,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.026","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T16:30:06Z","timestamp":1606667406000},"page":"746-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Safety profile of rotavirus vaccines among individuals aged\u202f\u22658\u202fmonths of age, United States, vaccine adverse event reporting system (VAERS), 2006\u20132019"],"prefix":"10.1016","volume":"39","author":[{"given":"Penina","family":"Haber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.026_b0005","unstructured":"Food and Drug Administration, Product-approval information-licensing action [package insert] RotaTeq (rotavirus vaccine, live, oral, pentavalent), Merck & Co. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, 2011. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/r\/rotateq\/rotateq_pi.pdf. Accessed 29 June 2020"},{"key":"10.1016\/j.vaccine.2020.11.026_b0010","unstructured":"Food and Drug Administration, Product-approval information-licensing action [package insert]. Rotarix (rotavirus vaccine, live, oral), GlaxoSmithKline Biologicals. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, 2011. Available at 2020. https:\/\/www.fda.gov\/media\/75718\/download. Accessed 06 March 2020."},{"key":"10.1016\/j.vaccine.2020.11.026_b0015","unstructured":"Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999;48(43):1007"},{"key":"10.1016\/j.vaccine.2020.11.026_b0020","unstructured":"Centers for Disease Control and Prevention Intussusception among recipients of rotavirus vaccine\u2013United States, 1998\u20131999. MMWR Morb Mortal Wkly Rep 1999;48(27):577\u2013581"},{"key":"10.1016\/j.vaccine.2020.11.026_b0025","unstructured":"Suspension of Rotavirus vaccine after reports of intussusception -United States, 1999 MMWR, 3 September, 2004\/53 (43);786\u2013789"},{"key":"10.1016\/j.vaccine.2020.11.026_b0030","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: The role of age at the time of vaccination","volume":"192","author":"Simonsen","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.11.026_b0035","doi-asserted-by":"crossref","first-page":"e68482","DOI":"10.1371\/journal.pone.0068482","volume":"8","author":"Jiang","year":"2013","journal-title":"Lit Rev PLoS One"},{"issue":"RR-12","key":"10.1016\/j.vaccine.2020.11.026_b0040","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Parashar","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.026_b0045","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1542\/peds.2005-2874","article-title":"Rotavirus Vaccination and Intussusception: Can We Decrease Temporally Associated Background Cases of Intussusception by Restricting the Vaccination Schedule?","volume":"118","author":"Tai","year":"2006","journal-title":"Pediatrics."},{"issue":"RR-2","key":"10.1016\/j.vaccine.2020.11.026_b0050","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"58","author":"Cortesee","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2020.11.026_b0055","doi-asserted-by":"crossref","first-page":"e1912458","DOI":"10.1001\/jamanetworkopen.2019.12458","article-title":"Association between rotavirus vaccination and risk of intussusception among neonates and infants: A systematic review and meta-analysis","volume":"2","author":"Hai-Ling","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.vaccine.2020.11.026_b0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"intussusception after rotavirus vaccines reported to US VAERS","volume":"131","author":"Haber","year":"2006","journal-title":"Pediatrics"},{"issue":"380","key":"10.1016\/j.vaccine.2020.11.026_b0065","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.vaccine.2015.07.054","article-title":"Intussusception after monovalent rotavirus vaccine-United States, vaccine adverse event reporting system (VAERS), 2008\u20132014","volume":"33","author":"Haber","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.026_b0070","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.026_b0075","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine adverse event reporting system (VAERS)\u2013United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ."},{"key":"10.1016\/j.vaccine.2020.11.026_b0080","unstructured":"Medical dictionary for regulatory activities. https:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_20_1_english_0.pdf."},{"key":"10.1016\/j.vaccine.2020.11.026_b0085","unstructured":"21 CFR Part 600.80 Postmarketing of adverse Experiences. Code of Federal Regulations Title 21. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfCFR\/CFRSearch.cfm?fr=600.80."},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.026_b0090","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1542\/peds.2007-1590","article-title":"Trends in intussusception hospitalizations among US infants, 1993\u20132004: Implications for monitoring the safety of the new rotavirus vaccination program","volume":"121","author":"Jacqueline","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.026_b0095","first-page":"e438","article-title":"Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis","volume":"125","author":"Payne","year":"2010","journal-title":"Case Reports Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2020.11.026_b0100","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/infdis\/jis490","article-title":"Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: A case series case reports","volume":"206","author":"Boom","year":"2012","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.026_b0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-016-0482-1","article-title":"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010-May 2016","volume":"40","author":"Moro","year":"2017","journal-title":"Drug Saf"},{"issue":"39","key":"10.1016\/j.vaccine.2020.11.026_b0110","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1016\/j.vaccine.2012.04.005","article-title":"Causality working group of the clinical immunization safety assessment network. Algorithm to assess causality after individual adverse events following immunizations","volume":"30","author":"Halsey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.026_b0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14760584.2019.1676154","article-title":"Challenges in evaluating post-licensure vaccine safety: Observations from the Centers for Disease Control and Prevention","volume":"18","author":"Moro","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.11.026_b0120","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The vaccine safety datalink: Successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:10Z","timestamp":1759402390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20314663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20314663"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety profile of rotavirus vaccines among individuals aged\u202f\u22658\u202fmonths of age, United States, vaccine adverse event reporting system (VAERS), 2006\u20132019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}